Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$555.84
-2.19-0.39%
À la fermeture: Nov 21, 4:00 PM EST
$559.50
3.660.66%
Après les heures de négociation: 7:45 PM EST
Comments
Loading...
Évaluations des analystes, objectifs de prix, prévision
GE Vernova Inc a un objectif de cours consensuel de $613.08 basé sur les évaluations de 27 analystes. Le plus élevé est $758, publié par GLJ Research le octobre 15, 2025. Le plus bas est $336, publié par Daiwa Capital le octobre 30, 2024. Les 3 évaluations d’analystes les plus récentes ont été publiées par Morgan Stanley, Wells Fargo et Mizuho le octobre 30, 2025, octobre 24, 2025 et octobre 24, 2025, respectivement. Avec un objectif de cours moyen de $695.67 entre Morgan Stanley, Wells Fargo et Mizuho, il existe une variation implicite de 24.34% upside pour GE Vernova Inc selon ces dernières évaluations d’analystes.
Sociétés d'analyse émettant des recommandations1
Morgan Stanley
Wells Fargo
Mizuho
JP Morgan
TD Cowen
1calculé à partir des notes des analystes
Notes d'analystes pour GE Vernova
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/30/2025 | 26.9% | Morgan Stanley | $690 → $710 | Maintains | Overweight | |||
10/24/2025 | 28.15% | Wells Fargo | $697 → $717 | Maintains | Overweight | |||
10/24/2025 | 17.96% | Mizuho | $677 → $660 | Maintains | Neutral | |||
10/23/2025 | 32.26% | JP Morgan | $715 → $740 | Maintains | Overweight | |||
10/23/2025 | 21.54% | TD Cowen | $685 → $680 | Maintains | Buy | |||
10/23/2025 | 34.05% | Susquehanna | $740 → $750 | Maintains | Positive | |||
10/23/2025 | 12.6% | RBC Capital | $605 → $630 | Maintains | Sector Perform | |||
10/23/2025 | 26.9% | BMO Capital | $690 → $710 | Maintains | Outperform | |||
10/23/2025 | 26.9% | Barclays | $706 → $710 | Maintains | Overweight | |||
10/23/2025 | 17.61% | Citigroup | $670 → $658 | Maintains | Neutral | |||
10/16/2025 | 23.32% | Morgan Stanley | $675 → $690 | Maintains | Overweight | |||
10/15/2025 | 35.48% | GLJ Research | $702 → $758 | Maintains | Buy | |||
10/15/2025 | 21% | Mizuho | $670 → $677 | Maintains | Neutral | |||
10/15/2025 | -15.1% | Rothschild & Co | → $475 | Downgrade | Neutral → Sell | |||
10/13/2025 | 32.26% | Susquehanna | $736 → $740 | Maintains | Positive | |||
09/15/2025 | 32.26% | Melius Research | → $740 | Upgrade | Hold → Buy | |||
09/12/2025 | 19.39% | Jefferies | $658 → $668 | Maintains | Hold | |||
09/05/2025 | 3.66% | HSBC | $570 → $580 | Maintains | Hold | |||
08/15/2025 | 17.61% | Jefferies | $620 → $658 | Maintains | Hold | |||
07/24/2025 | 19.75% | Citigroup | $544 → $670 | Maintains | Neutral | |||
07/24/2025 | 23.32% | BMO Capital | $590 → $690 | Maintains | Outperform | |||
07/24/2025 | 27.79% | JP Morgan | $620 → $715 | Maintains | Overweight | |||
07/24/2025 | 31.55% | Susquehanna | $662 → $736 | Maintains | Positive | |||
07/24/2025 | 24.58% | Wells Fargo | $474 → $697 | Maintains | Overweight | |||
07/24/2025 | 20.64% | Morgan Stanley | $511 → $675 | Maintains | Overweight | |||
07/24/2025 | 26.18% | Barclays | $580 → $706 | Maintains | Overweight | |||
07/24/2025 | 26.18% | Baird | $568 → $706 | Maintains | Outperform | |||
07/17/2025 | 10.81% | B of A Securities | $550 → $620 | Maintains | Buy | |||
07/16/2025 | 10.81% | JP Morgan | $460 → $620 | Maintains | Overweight | |||
07/14/2025 | -2.77% | Citigroup | $354 → $544 | Maintains | Neutral | |||
07/10/2025 | 12.6% | Seaport Global | → $630 | Initiates | → Buy | |||
07/09/2025 | 3.66% | Barclays | $550 → $580 | Maintains | Overweight | |||
07/08/2025 | 5.45% | BMO Capital | $522 → $590 | Maintains | Outperform | |||
07/07/2025 | 9.74% | UBS | → $614 | Initiates | → Buy | |||
06/24/2025 | -8.67% | Morgan Stanley | $422 → $511 | Maintains | Overweight | |||
06/23/2025 | 25.47% | GLJ Research | → $702 | Initiates | → Buy | |||
06/13/2025 | — | Wolfe Research | — | Downgrade | Outperform → Peer Perform | |||
06/11/2025 | -1.7% | B of A Securities | $520 → $550 | Maintains | Buy | |||
06/10/2025 | 1.88% | Goldman Sachs | $500 → $570 | Maintains | Buy | |||
06/09/2025 | -1.7% | Barclays | $500 → $550 | Maintains | Overweight | |||
05/30/2025 | -6.7% | BMO Capital | $381 → $522 | Maintains | Outperform | |||
05/30/2025 | -10.63% | Barclays | $427 → $500 | Maintains | Overweight | |||
05/29/2025 | -7.6% | Jefferies | $427 → $517 | Downgrade | Buy → Hold | |||
05/16/2025 | -17.78% | JP Morgan | $430 → $460 | Maintains | Overweight | |||
05/14/2025 | -10.81% | Susquehanna | $399 → $499 | Maintains | Positive | |||
04/25/2025 | -23.68% | Jefferies | $418 → $427 | Maintains | Buy | |||
04/24/2025 | -32.08% | Guggenheim | $380 → $380 | Reiterates | Buy → Buy | |||
04/24/2025 | -24.58% | Morgan Stanley | $400 → $422 | Maintains | Overweight | |||
04/24/2025 | -28.69% | Susquehanna | $370 → $399 | Maintains | Positive | |||
04/24/2025 | -27.61% | Baird | $387 → $405 | Maintains | Outperform | |||
04/23/2025 | -23.15% | JP Morgan | $425 → $430 | Maintains | Overweight | |||
04/17/2025 | -25.29% | Jefferies | $413 → $418 | Maintains | Buy | |||
04/17/2025 | -32.08% | Guggenheim | $380 → $380 | Reiterates | Buy → Buy | |||
04/15/2025 | -30.83% | Baird | $448 → $387 | Maintains | Outperform | |||
04/14/2025 | -36.73% | Citigroup | $437 → $354 | Maintains | Neutral | |||
04/10/2025 | -24.04% | JP Morgan | $436 → $425 | Maintains | Overweight | |||
04/09/2025 | -31.9% | BMO Capital | $420 → $381 | Maintains | Outperform | |||
04/02/2025 | -33.87% | Susquehanna | → $370 | Initiates | → Positive | |||
03/27/2025 | -26.18% | Jefferies | $391 → $413 | Maintains | Buy | |||
03/18/2025 | -20.46% | RBC Capital | $453 → $445 | Maintains | Outperform | |||
03/05/2025 | -32.08% | Guggenheim | → $380 | Upgrade | Neutral → Buy | |||
03/03/2025 | -24.93% | BMO Capital | $471 → $420 | Maintains | Outperform | |||
03/03/2025 | -23.68% | Barclays | $487 → $427 | Maintains | Overweight | |||
02/19/2025 | — | CICC | — | Initiates | → Outperform | |||
02/13/2025 | -19.93% | Baird | → $448 | Initiates | → Outperform | |||
02/07/2025 | -24.04% | Johnson Rice | → $425 | Initiates | → Buy | |||
01/28/2025 | -19.03% | RBC Capital | $453 → $453 | Reiterates | Outperform → Outperform | |||
01/24/2025 | -32.08% | Guggenheim | $380 → $380 | Downgrade | Buy → Neutral | |||
01/24/2025 | -10.63% | Goldman Sachs | $446 → $500 | Maintains | Buy | |||
01/23/2025 | -16% | Truist Securities | $420 → $470 | Maintains | Buy | |||
01/23/2025 | -15.82% | BMO Capital | $420 → $471 | Maintains | Outperform | |||
01/23/2025 | -21.89% | Citigroup | $361 → $437 | Maintains | Neutral | |||
01/23/2025 | -12.96% | Barclays | $420 → $487 | Maintains | Overweight | |||
01/23/2025 | -22.07% | JP Morgan | $374 → $436 | Maintains | Overweight | |||
01/21/2025 | -24.93% | BMO Capital | $360 → $420 | Maintains | Outperform | |||
01/21/2025 | -7.06% | B of A Securities | $415 → $520 | Reiterates | Buy → Buy | |||
01/16/2025 | -20.29% | Goldman Sachs | $400 → $446 | Maintains | Buy | |||
01/16/2025 | -24.93% | Truist Securities | $400 → $420 | Maintains | Buy | |||
01/14/2025 | -25.83% | B of A Securities | $380 → $415 | Maintains | Buy | |||
01/14/2025 | -33.15% | JP Morgan | $367 → $374 | Maintains | Overweight | |||
12/13/2024 | -26.54% | Wells Fargo | $385 → $411 | Maintains | Overweight | |||
12/13/2024 | -30.12% | Jefferies | $348 → $391 | Maintains | Buy | |||
12/12/2024 | -28.51% | Goldman Sachs | $324 → $400 | Maintains | Buy | |||
12/11/2024 | -34.41% | JP Morgan | $356 → $367 | Maintains | Overweight | |||
12/11/2024 | -30.29% | Evercore ISI Group | $385 → $390 | Maintains | Outperform | |||
12/11/2024 | -32.08% | Guggenheim | $400 → $380 | Maintains | Buy | |||
12/11/2024 | -32.8% | RBC Capital | $376 → $376 | Reiterates | Outperform → Outperform | |||
12/10/2024 | -28.51% | Truist Securities | $325 → $400 | Maintains | Buy | |||
12/09/2024 | -35.48% | Citigroup | $292 → $361 | Maintains | Neutral | |||
12/05/2024 | -24.93% | Barclays | $320 → $420 | Maintains | Overweight | |||
12/05/2024 | -28.51% | Guggenheim | $300 → $400 | Maintains | Buy | |||
12/04/2024 | -27.97% | Wolfe Research | → $403 | Initiates | → Outperform | |||
12/03/2024 | -36.37% | JP Morgan | $330 → $356 | Maintains | Overweight | |||
11/25/2024 | -32.8% | RBC Capital | $285 → $376 | Maintains | Outperform | |||
11/21/2024 | -31.19% | Wells Fargo | → $385 | Initiates | → Overweight | |||
11/15/2024 | -34.41% | Morgan Stanley | $301 → $367 | Maintains | Overweight | |||
10/30/2024 | -39.95% | Daiwa Capital | $245 → $336 | Upgrade | Outperform → Buy | |||
10/24/2024 | -41.91% | Truist Securities | $300 → $325 | Maintains | Buy | |||
10/24/2024 | -46.2% | Morgan Stanley | $256 → $301 | Maintains | Overweight | |||
10/24/2024 | -49.06% | RBC Capital | $262 → $285 | Maintains | Outperform |
FAQ
Quel est le cours indicatif de l'action GE Vernova (GEV) ?
Le dernier objectif de prix pour GE Vernova (NYSE:GEV) a été rapporté par Morgan Stanley le octobre 30, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $710.00 s'attendant à ce que GEV se rise dans les 12 prochains mois (un possible changement de 26.90% upside). 94 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
Quelle est la note d'analyste la plus récente pour GE Vernova (GEV) ?
La dernière note d'analyste pour GE Vernova (NYSE:GEV) a été fournie par Morgan Stanley, et GE Vernova maintenu leur note overweight.
Quand a eu lieu la dernière mise à niveau pour GE Vernova (GEV) ?
La dernière amélioration pour GE Vernova Inc a eu lieu le septembre 15, 2025 lorsque Melius Research a augmenté leur objectif de prix à $740. Melius Research avait précédemment a hold pour GE Vernova Inc.
Quand a eu lieu la dernière dégradation pour GE Vernova (GEV) ?
La dernière réduction pour GE Vernova Inc a eu lieu le octobre 15, 2025 lorsque Rothschild & Co a changé leur objectif de prix de N/A à $475 pour GE Vernova Inc.
Quand la prochaine note d'analyste sera-t-elle publiée ou mise à jour pour GE Vernova (GEV) ?
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de GE Vernova, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour GE Vernova a été déposée le octobre 30, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers octobre 30, 2026.
La note d'analyste pour GE Vernova (GEV) est-elle correcte ?
Bien que les évaluations soient subjectives et changeront, la dernière note de GE Vernova (GEV) était un maintenu avec un objectif de prix de $690.00 à $710.00. Le prix actuel de GE Vernova (GEV) est de $559.50, ce qui est out of la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.